Relating to the definition of an epinephrine delivery device and the use of those devices in public and private schools.
The bill’s provisions will require school districts, charter schools, and private schools to create and implement policies related to the administration of epinephrine delivery devices. Additionally, these institutions will need to ensure that trained personnel are available on campuses to administer the devices during emergencies. The legislation also allows for the standing orders for epinephrine delivery devices to be non-patient-specific, thereby streamlining the process by which these medications can be administered in a timely manner without requiring a pre-established physician-patient relationship.
House Bill 2801 addresses the definition and administration of epinephrine delivery devices, including auto-injectors and nasal sprays, specifically in public and private school settings. This legislation aims to enhance the preparedness of schools in treating allergic reactions effectively by updating existing education laws. The bill establishes a clearer definition of what constitutes an epinephrine delivery device and sets forth protocols for schools to follow regarding their maintenance, administration, and disposal.
Notable points of contention around HB 2801 potentially arise from concerns related to liability and the adequacy of training provided to school personnel. While the bill includes provisions for immunity from civil or criminal liability for those acting in good faith, there remain discussions about whether the training requirements sufficiently equip school staff to handle anaphylaxis emergencies effectively. There may also be debates regarding how schools inventory and manage supplies of epinephrine delivery devices, ensuring they are accessible while still adhering to safety standards.